“Antibody response to breakthrough SARS-CoV-2 infection in ‘booster’ vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments” (2024) Mediterranean Journal of Hematology and Infectious Diseases, 16(1), p. e2024022. doi:10.4084/MJHID.2024.022.